GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
First Time in Human Study With GSK1018921
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2007-09-10
- Last Posted Date
- 2017-08-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 27
- Registration Number
- NCT00527020
- Locations
- 🇩🇪
GSK Investigational Site, Berlin, Germany
Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine
- Conditions
- Hepatitis B
- Interventions
- Biological: Engerix™-B
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2018-09-07
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 144
- Registration Number
- NCT00524576
- Locations
- 🇧🇪
GSK Investigational Site, Wilrijk, Belgium
A Study Of BRL49653C For The Treatment Of Type 2 Diabetes
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 70
- Registration Number
- NCT00523913
- Locations
GSK Investigational Site
Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.
- Conditions
- Neoplasms, Breast
- Interventions
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2016-11-11
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 100
- Registration Number
- NCT00524303
- Locations
- 🇺🇸
GSK Investigational Site, Yakima, Washington, United States
Exploratory Study in Healthy Elderly Subjects to Collect Urine for Development of Assays to Detect S. Pneumoniae
- Conditions
- Infections, Streptococcal
- Interventions
- Procedure: Urine sample collection
- First Posted Date
- 2007-08-31
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 50
- Registration Number
- NCT00523770
Repeat Dose GW685698X With Magnesium Stearate, Excipient Bridging Study, In Healthy Volunteers
- First Posted Date
- 2007-08-30
- Last Posted Date
- 2017-08-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 36
- Registration Number
- NCT00522678
- Locations
- 🇦🇺
GSK Investigational Site, Melbourne, Victoria, Australia
Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug
- Conditions
- Sleep Initiation and Maintenance Disorders
- Interventions
- Drug: 14C-SB649868
- First Posted Date
- 2007-08-24
- Last Posted Date
- 2017-08-02
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 8
- Registration Number
- NCT00520663
- Locations
- 🇬🇧
GSK Investigational Site, Tranent, West Lothian, United Kingdom
Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria
- Conditions
- Malaria
- First Posted Date
- 2007-08-22
- Last Posted Date
- 2016-12-06
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 120
- Registration Number
- NCT00519467
- Locations
- 🇲🇼
GSK Investigational Site, Blantyre, Malawi
A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients.
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- Drug: GW642444MDrug: GW642444HDrug: placebo
- First Posted Date
- 2007-08-22
- Last Posted Date
- 2017-03-23
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 20
- Registration Number
- NCT00519376
- Locations
- 🇩🇪
GSK Investigational Site, Berlin, Germany
A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2007-08-22
- Last Posted Date
- 2017-09-06
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 50
- Registration Number
- NCT00519480
- Locations
- 🇩🇪
GSK Investigational Site, Berlin, Germany